Funding for this research was provided by:
National Natural Science Foundation of China (81773120, 81702963, 81972882)
Received: 5 June 2020
Revised: 8 September 2020
Accepted: 11 September 2020
First Online: 25 September 2020
Ethics approval and consent to participate
: All the breast cancer clinical samples were obtained from The Third People’s Hospital of Chengdu and Sichuan Cancer Center. This study was approved by the institutional ethics committees of The Third People’s Hospital of Chengdu. All patients signed an informed consent. All of the animal experiments were approved by the Nankai University Animal Care and Use Committee and handled according to the Nankai University Animal Welfare Guidelines.
: The authors confirmed that they have obtained written consent from the patient to publish the manuscript.
: The authors declare that they have no conflict of interest.